INTRODUCTION
Hepatic encephalopathy (HE) is a serious complication of decompensated cirrhosis that manifests as a wide range of neuropsychological clinical findings ranging from minimal HE to coma [1] . HE can be classified as either 'overt' or 'minimal'. Overt He (oHE) is a syndrome of neurological and neuronpsychiatric abnormalities that can be detected by bedside clinical tests. By contrast, patients with minimal He (mHE) present with normal mental and neurological status upon clinical examination but specific psychometric tests yield abnormal results [2] . Despite the important progresses of neuron imaging methods, clinical scales are commonly considered the best way to assess the degree of impairment and its impact on daily life activities for the majority of neurological diseases.
Previous studies recommended using clinical scales for grading hepatic encephalopathy and to report efficacy in therapeutic trials such as the WestHaven criteria and Glasgow Coma Scale to assess the severity of HE [3] .
The model for end-stage liver disease (MELD) score was introduced to evaluate hepatic functions in cirrhotic patients. It has the advantage of using three objective and easily measured parameters: creatinine levels, international normalized ratio (INR) and total bilirubin [4] . The Model for End-Stage Liver Disease (MELD) score has been adopted as an objective indicator of liver disease severity [1] .
Aim of the work: this study aims at assessing the significance of Glasgow coma scale in evaluation of patients with hepatic encephalopathy in comparison to the standard West-Haven criteria and its ability to predict morbidity and mortality in patients with hepatic encephalopathy in comparison with MELD score.
PATIENTS AND METHODS
This study was carried out on 100 patients with liver cirrhosis and overt Hepatic Encephalopathy. They were 85 males (85%) and15 females (15%), and their ages ranged between 18 and 60 years. All cases were selected from the Department of Hepatology, Gastroenterology and Infectious Diseases, Mansoura Health Insurance Hospital, within the period between January 2014 to June 2014.
The exclusion criteria were severe cardio-pulmonary disease, sepsis, renal disease, hepatocellular carcinoma, diabetes mellitus, patients listed to undergo transplantation.
Patients were subjected to the following: Full history taking, thorough clinical examination. Routine laboratory investigations, that included: Complete blood picture. Liver profile tests: prothrombin time and concentration S. creatinine, viral markers, arterial blood ammonia.
Samples collection, preparation and handling:
A sample of arterial blood was sampled soon after admission under aseptic condition in preheparinized syringes from indwelling radial or femoral arterial catheters. Admission samples were taken within 24 hours of admission. Ammonia was measured with Ammonia Test Kit II for the PocketChem BA device (Arkay, Inc., Kyoto, Japan).
Abdominal Ultrasonography:
Liver was assessed for: size (span), echogenicity, surface, thickening of portal tracts, portal vein diameter, hepatic veins, inferior vena cava and presence or absence of focal lesions.
Spleen was assessed for: size, echogenicity, splenic vein diameter and presence or absence of collaterals. Other data concerning the gall bladder, both kidneys, pancreas, para aortic region as well as detection of ascites all were fulfilled. In the statistical comparison between the different groups, the significance of difference was tested using one of the following tests :
A-Student's t-test:-Used to compare between mean of two groups of numerical (parametric) data. B-Mann Whitney U test: Used to compare between two groups of numerical (nonparametric) data. C-Kruskal Wallis test: Used to compare between more than two groups of numerical (non-parametric) data followed by Mann Whitney for multiple comparisons.
Significance level: For all above mentioned statistical tests done, the threshold of significance is fixed at 5% level (p-value). The results were considered: Non-significant when the probability of error is more than 5% (p > 0.05). Significant when the probability of error is less than 5% (p≤0.05). Highly significant when the probability of error is less than 0.1% (p ≤0.001).
RESULTS
The study was conducted on 100 patients (cases group) 85 males (85%), 15 females (15%). the age ranged between 47 and 77 years old in group (1) cases with the mean age being 60.28±7.54 years in comparison with group (4), the age ranged between 50 and 66 years old with mean age 56.50±6.95 years. Table (1) All patients complained from disturbed consciousness.
The mean value of Serum Creatinine was significantly higher in group (3) group than in other groups. No statistical significant difference between the four groups as regards ALT, AST, alkaline phosphatase, total bilirubin, prothrombin concentration, INR and albumin ( Table 2 ).
As shown in table (2) there was statistical significant difference between the four groups as regards the arterial blood ammonia. It was significantly more predominant in group (4) cases (356.50±47.93) than in group (1) cases (90.73±18.42).
As shown in table ( 3) The most cases of Child A were in group (2), most cases of Child B were in group (1), and most cases of Child C were in group (3) with statistical significant difference between the four groups. The mean value of Child score was predominant in group (3) cases (10± 1.087) with highly statistical significant difference between the four groups. As regards the severity of liver disease, MELD score was predominantly high in group (3) cases (24.43± 6.45) in comparison with group (1) patients (18.52± 4.62). Also uMELD score was high in group (3) cases with statistically significant difference between the four groups. There was statistical significant difference between the four groups as regards the severity of neurological dysfunction assessed by Glasgow Coma Scale. The GCS was predominantly high in group (1) cases, and less in group (4) cases.
As shown in table (4) average cirrhotic liver was detected in 78.9% of group (1) cases in comparison with group (4) cases (25.0%). Enlarged cirrhotic liver was detected predominant in group (4) cases, while shrunken liver was present predominant in group (3) cases and was statistically significant. Splenomegaly was detected in 100% of group (1-3-4) cases compared to 97.1% of group (2) cases which was statistically not significant. Portal Vein Dilatation was detected predominant in group (4) cases (100%) in comparison with group (1) cases which was present in (63.1%) and was statistically significant. There was no statistically significant difference among the four groups as regards the portal vein dilatation, splenic vein dilatation, collaterals, and gall bladder. There was statistical significant difference between the four groups as regards ascites. Mild ascites was significantly more predominant in group (4) patients (50.0%) than in other groups. Moderate ascites was significantly more predominant in group (1) patients (63.2%) than in other groups. Severe ascites was significantly more predominant in group (3) patients (56.5%) than in other groups.
As shown in table (5) there was statistically significant difference as regards the mortality among the studied patients being more predominant in group (3) patients (87%) in comparison with group (1) cases (34.2%). West Haven Criteria had significant influence on overall survival of patients with hepatic encephalopathy .There was a longest survival time (mean 8.9 months) in the group (1), followed by a longer survival time (mean 4.13 months) in the group (2) and a shorter survival time (mean 2.8 months) in the group (4) and the shortest survival time (mean 2.11months) in the group (3) which was statistically significant. Table (6) GCS had significant influence on overall survival of patients with hepatic encephalopathy. After one year, survival was predominant in score (11.76±1.93) and death in score (9.24±2.95). MELD score had significant influence on overall survival of patients with HE. After one year, survival was predominantly high when MELD score was early (17.64±4.29) and death occurred when the score was advanced (23.10±6.52). Also uMELD score affected on overall survival of patients with HE. After one year, survival was high when uMELD score was early (3.94±.489) and death occurred when the score (4.57±.737) was advanced with high significant statistically difference. Child score affected on overall survival of patients with HE. Survival was high when score was small (8.38±1.04) and death occurred when the score increased (9.18±1.27) with significant statistically difference between all groups. Table (7) As shown in table (8) according to Cox regression, there was no difference in prediction of survival among the studied patients assessed by GCS, MELD score, uMELD score and Child score (all had the same results). who documented that mean plasma ammonia levels were increase with the severity of HE. Our findings support the final report of the working party at the 11 th world congresses of gastroenterology ammonia testing was described as a potential diagnostic tool which, however, correlates poorly with symptoms of HE [9] .
In this study, most cases of Child A (2.9%) were in Group (2), most cases of Child B (81.6%) were in Group (1), and most cases of Child C (65.2) were in Group (3) with statistical significant difference between the four groups. These results were in agreement with Stewart et al. The mean value of Child score was predominantly high in most of patients (group (3) cases) (10± 1.087) with highly statistical significant difference between the four groups. These results were in agreement with Wehler (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) , in Group (2) patients were (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) , and in Group (1) patients were (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) , and Laferrière et al. [24] who documented nearly the same results with a median of 22 (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) in Group (3) patients, and with that who reported that most of the patients with Group (2-4)cases were presented at advanced score (22 ± 9) and Group (1) In the present study, Glasgow Coma Scale had a significant influence on overall survival of patients with HE, overall survival was shorter in patients with lower score and longer with higher score. This result was in agreement with Mouri et al. [14] who documented the same results.
CONCLUSION
Glasgow coma scale can help assess patients with hepatic encephalopathy and can with great accuracy assess risk of one year mortality.
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